Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices.

Ghanbari H, Phard WS, Al-Ameri H, Latchamsetty R, Jongnarngsin K, Crawford T, Good E, Chugh A, Oral H, Bogun F, Morady F, Pelosi F Jr.

Am J Cardiol. 2012 Nov 15;110(10):1482-8. doi: 10.1016/j.amjcard.2012.06.057. Epub 2012 Aug 17. Review.

PMID:
22906894
2.

Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.

Jamula E, Douketis JD, Schulman S.

J Thromb Haemost. 2008 Oct;6(10):1615-21. doi: 10.1111/j.1538-7836.2008.03080.x. Epub 2008 Jul 12. Review.

3.

The safety and efficacy of antithrombotic therapy in patients undergoing cardiac rhythm device implantation: a meta-analysis.

Yang X, Wang Z, Zhang Y, Yin X, Hou Y.

Europace. 2015 Jul;17(7):1076-84. doi: 10.1093/europace/euu369. Epub 2015 Feb 18. Review.

PMID:
25713013
4.

Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.

Du L, Zhang Y, Wang W, Hou Y.

Pacing Clin Electrophysiol. 2014 Nov;37(11):1573-86. doi: 10.1111/pace.12517. Epub 2014 Sep 19.

PMID:
25234639
5.

Meta-analysis of continuous oral anticoagulants versus heparin bridging in patients undergoing CIED surgery: reappraisal after the BRUISE study.

Sant'anna RT, Leiria TL, Nascimento T, Sant'anna JR, Kalil RA, Lima GG, Verma A, Healey JS, Birnie DH, Essebag V.

Pacing Clin Electrophysiol. 2015 Apr;38(4):417-23. doi: 10.1111/pace.12557. Epub 2014 Dec 26. Review.

PMID:
25546244
6.

Pacemaker or defibrillator surgery without interruption of anticoagulation.

Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leiria TL, Essebag V; BRUISE CONTROL Investigators.

N Engl J Med. 2013 May 30;368(22):2084-93. doi: 10.1056/NEJMoa1302946. Epub 2013 May 9.

7.

Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial.

Cheng A, Nazarian S, Brinker JA, Tompkins C, Spragg DD, Leng CT, Halperin H, Tandri H, Sinha SK, Marine JE, Calkins H, Tomaselli GF, Berger RD, Henrikson CA.

Heart Rhythm. 2011 Apr;8(4):536-40. doi: 10.1016/j.hrthm.2010.12.016. Epub 2010 Dec 13.

PMID:
21147261
8.

Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.

Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, Nazarian S, Spragg DD, Sinha S, Halperin H, Tomaselli GF, Berger RD, Calkins H, Henrikson CA.

J Am Coll Cardiol. 2010 May 25;55(21):2376-82. doi: 10.1016/j.jacc.2009.12.056.

9.

Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.

Tischenko A, Gula LJ, Yee R, Klein GJ, Skanes AC, Krahn AD.

Am Heart J. 2009 Aug;158(2):252-6. doi: 10.1016/j.ahj.2009.06.005.

PMID:
19619702
10.

Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.

Jennings JM, Robichaux R, McElderry HT, Plumb VJ, Gunter A, Doppalapudi H, Osorio J, Yamada T, Kay GN.

J Cardiovasc Electrophysiol. 2013 Oct;24(10):1125-9. doi: 10.1111/jce.12214. Epub 2013 Jul 25.

PMID:
23889767
11.

Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.

Siegal D, Yudin J, Kaatz S, Douketis JD, Lim W, Spyropoulos AC.

Circulation. 2012 Sep 25;126(13):1630-9. Epub 2012 Aug 21. Review.

12.

Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios.

Ghanbari H, Feldman D, Schmidt M, Ottino J, Machado C, Akoum N, Wall TS, Daccarett M.

Pacing Clin Electrophysiol. 2010 Apr;33(4):400-6. doi: 10.1111/j.1540-8159.2010.02703.x. Epub 2010 Feb 18.

PMID:
20180915
13.

Cardiac rhythm device surgery with uninterrupted oral anticoagulation.

Tyagi G, Pai SM, Pai RG.

Future Cardiol. 2013 Nov;9(6):763-6. doi: 10.2217/fca.13.80.

PMID:
24180532
14.

Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.

Ahmed I, Gertner E, Nelson WB, House CM, Dahiya R, Anderson CP, Benditt DG, Zhu DW.

Heart Rhythm. 2010 Jun;7(6):745-9. doi: 10.1016/j.hrthm.2010.02.018. Epub 2010 Feb 20.

PMID:
20176137
15.

Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies.

Proietti R, Porto I, Levi M, Leo A, Russo V, Kalfon E, Biondi-Zoccai G, Roux JF, Birnie DH, Essebag V.

Eur Rev Med Pharmacol Sci. 2015 Apr;19(8):1461-79. Review.

16.

Oral anticoagulation continuation compared with heparin bridging therapy among high risk patients undergoing implantation of cardiac rhythm devices: a meta-analysis.

Feng L, Li Y, Li J, Yu B.

Thromb Haemost. 2012 Dec;108(6):1124-31. doi: 10.1160/TH12-07-0498. Epub 2012 Oct 10. Review.

PMID:
23051884
17.

Implanting cardiac rhythm devices during uninterrupted warfarin therapy: a prospective, single center experience.

Crosato M, Calzolari V, Franceschini Grisolia E, Daniotti A, Baldessin F, Mantovan R, Olivari Z.

J Cardiovasc Med (Hagerstown). 2015 Jul;16(7):503-6. doi: 10.2459/JCM.0000000000000011.

PMID:
25022924
18.

Cost effectiveness of continued-warfarin versus heparin-bridging therapy during pacemaker and defibrillator surgery.

Coyle D, Coyle K, Essebag V, Birnie DH, Ahmad K, Toal S, Sapp J, Healey JS, Verma A, Wells G, Krahn AD.

J Am Coll Cardiol. 2015 Mar 10;65(9):957-9. doi: 10.1016/j.jacc.2014.11.060. No abstract available.

19.

Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial.

Schulman S, Healey JS, Douketis JD, Delaney J, Morillo CA.

Thromb Res. 2014 Oct;134(4):814-8. doi: 10.1016/j.thromres.2014.07.028. Epub 2014 Aug 1.

PMID:
25127655
20.

Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement.

Mathew JG, Spyropoulos AC, Yusuf A, Vincent J, Eikelboom J, Shestakovska O, Fremes S, Noora J, Guo L, Peterson M, Pai M, Whitlock R.

Thromb Haemost. 2014 Dec;112(6):1120-8. doi: 10.1160/TH14-03-0284. Epub 2014 Aug 28.

PMID:
25183209

Supplemental Content

Support Center